AstraZeneca PLC AZN | NASDAQ
After Hours
Company Overview:
10 Year AZN Performance Metrics:
AZN Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
AZN Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
AZN Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
AZN Dividends Info:
AZN Dividend History: Dates, Payments & Yield list
Below is a schedule of all AZN dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 02/21/2025 | 03/24/2025 | $1.050 | 2.07% | 2.83% | $74.09 |
| 08/09/2024 | 09/09/2024 | $0.490 | 1.82% | 1.21% | $80.89 |
| 02/22/2024 | 03/25/2024 | $0.985 | 2.26% | 2.99% | $65.86 |
| 08/10/2023 | 09/11/2023 | $0.465 | 2.06% | 1.4% | $66.60 |
| 02/23/2023 | 03/27/2023 | $0.985 | 2.15% | 2.87% | $68.73 |
| 08/11/2022 | 09/12/2022 | $0.465 | 2.24% | 1.51% | $61.75 |
| 02/24/2022 | 03/28/2022 | $0.985 | 2.47% | 3.01% | $65.38 |
| 08/12/2021 | 09/13/2021 | $0.450 | 2.44% | 1.61% | $55.96 |
| 02/25/2021 | 03/29/2021 | $0.950 | 2.86% | 3.74% | $50.81 |
| 08/13/2020 | 09/14/2020 | $0.450 | 2.51% | 1.67% | $54.02 |
| 02/27/2020 | 03/30/2020 | $0.950 | 3.11% | 4.27% | $44.53 |
| 08/08/2019 | 09/09/2019 | $0.450 | 3.17% | 2.05% | $43.80 |
| 02/28/2019 | 03/27/2019 | $0.950 | 3.37% | 4.45% | $42.65 |
| 08/09/2018 | 09/10/2018 | $0.450 | 3.53% | 2.38% | $37.75 |
| 02/15/2018 | 03/19/2018 | $0.950 | 4.12% | 5.5% | $34.57 |
| 08/09/2017 | 09/11/2017 | $0.450 | 4.75% | 2.73% | $32.99 |
| 02/15/2017 | 03/20/2017 | $0.950 | 4.85% | 6.19% | $30.70 |
| 08/10/2016 | 09/12/2016 | $0.450 | 4.17% | 2.71% | $33.24 |
| 02/17/2016 | 03/21/2016 | $0.950 | 4.66% | 6.69% | $28.40 |
| 08/12/2015 | 09/14/2015 | $0.450 | 4.19% | 2.71% | $33.17 |
| 02/18/2015 | 03/23/2015 | $0.950 | 4.14% | 5.26% | $36.11 |
| 08/13/2014 | 09/15/2014 | $0.450 | 4.09% | 2.44% | $36.89 |
| 02/19/2014 | 03/24/2014 | $0.950 | 4.26% | 5.94% | $31.96 |
| 08/14/2013 | 09/16/2013 | $0.450 | 5.57% | 3.51% | $25.66 |
| 02/13/2013 | 03/18/2013 | $0.950 | 6.11% | 8.23% | $23.09 |
| 08/08/2012 | 09/10/2012 | $0.450 | 6.04% | 3.87% | $23.28 |
| 02/15/2012 | 03/19/2012 | $0.975 | 6.19% | 8.59% | $22.69 |
| 08/04/2011 | 09/12/2011 | $0.425 | 6.12% | 3.88% | $21.92 |
| 02/02/2011 | 03/14/2011 | $0.925 | 5.34% | 7.82% | $23.66 |
| 08/04/2010 | 09/13/2010 | $0.350 | 4.69% | 2.7% | $25.92 |
| 02/03/2010 | 03/15/2010 | $0.855 | 5.11% | 7.72% | $22.16 |
| 08/05/2009 | 09/14/2009 | $0.295 | 4.47% | 2.6% | $22.70 |
| 09/06/2000 | 11/30/-0001 | $0.128 | 1.77% | 1.16% | $22.03 |
| 03/08/2000 | 11/30/-0001 | $0.261 | 2.13% | 2.86% | $18.25 |
| 09/08/1999 | 11/30/-0001 | $0.128 | 1.52% | 1.29% | $19.88 |
| 04/07/1999 | 11/30/-0001 | $0.175 | 1.37% | 1.51% | $23.13 |
| 09/16/1998 | 11/30/-0001 | $0.142 | 2.03% | 1.44% | $19.59 |
| 03/18/1998 | 11/30/-0001 | $0.256 | 1.78% | 2.34% | $21.84 |
| 09/17/1997 | 11/30/-0001 | $0.133 | 2.25% | 1.68% | $15.88 |
| 03/19/1997 | 11/30/-0001 | $0.224 | 2.43% | 3.17% | $14.13 |
| 09/20/1996 | 11/30/-0001 | $0.120 | 2.01% | 1.96% | $12.27 |
| 03/22/1996 | 11/30/-0001 | $0.127 | 2.29% | 2.43% | $10.42 |
| 09/22/1995 | 11/30/-0001 | $0.112 | 3.25% | 2.53% | $8.83 |
| 03/24/1995 | 11/30/-0001 | $0.175 | 3.92% | 4.94% | $7.10 |
| 09/23/1994 | 11/30/-0001 | $0.103 | 4.02% | 3.18% | $6.46 |
| 03/18/1994 | 11/30/-0001 | $0.157 | 4.51% | 5.58% | $5.63 |
| 09/24/1993 | 11/30/-0001 | $0.097 | 1.79% | 3.57% | $5.40 |
| 11/14/2000 | 11/30/-0001 | $0.537 | 2.77% | 4.47% | $24.03 |
| 02/21/2001 | 11/30/-0001 | $0.261 | 3.5% | 2.29% | $22.80 |
| 08/22/2001 | 11/30/-0001 | $0.128 | 1.58% | 1.04% | $24.55 |
| 08/06/2008 | 11/30/-0001 | $0.275 | 3.85% | 2.23% | $24.69 |
| 02/07/2008 | 11/30/-0001 | $0.675 | 4.83% | 6.97% | $19.36 |
| 08/08/2007 | 11/30/-0001 | $0.260 | 3.43% | 2.04% | $25.52 |
| 02/07/2007 | 11/30/-0001 | $0.615 | 2.97% | 4.24% | $29.00 |
| 08/09/2006 | 11/30/-0001 | $0.245 | 2.32% | 1.62% | $30.33 |
| 02/08/2006 | 11/30/-0001 | $0.460 | 2.81% | 3.97% | $23.17 |
| 08/10/2005 | 11/30/-0001 | $0.190 | 2.21% | 1.64% | $23.23 |
| 02/09/2005 | 11/30/-0001 | $0.323 | 2.39% | 3.28% | $19.64 |
| 08/11/2004 | 11/30/-0001 | $0.148 | 1.9% | 1.34% | $21.96 |
| 02/18/2004 | 11/30/-0001 | $0.270 | 1.64% | 2.23% | $24.22 |
| 08/20/2003 | 11/30/-0001 | $0.128 | 1.91% | 1.26% | $20.30 |
| 02/19/2003 | 11/30/-0001 | $0.261 | 2.26% | 3.03% | $17.20 |
| 08/21/2002 | 11/30/-0001 | $0.128 | 2.56% | 1.68% | $15.20 |
| 02/20/2002 | 11/30/-0001 | $0.261 | 1.57% | 2.1% | $24.85 |
| 02/04/2009 | 11/30/-0001 | $0.750 | 5.44% | 7.96% | $18.84 |
Projected Future Returns & Dividends for AZN
Based on past 10-year performance, here are AZN growth metrics:
Share price CAGR of +7.15%
Dividend CAGR of +1.01%
Using AZN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| AZN (DRIP) | AZN - No DRIP | |
|---|---|---|
| Current Price | $69.68 | $69.68 |
| Start Shares | 143.51 | 143.51 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 228.70 | 143.51 |
| Dividends Payment | $1.16 | $1.16 |
| Annual Dividends | $1,062 | $666 |
| Yield on cost | 10.62% | 6.66% |
| Share Price | $129.73 | $129.73 |
| Total Dividends | $8,201 | $6,308 |
| Final Value | $29,668 | $24,925 |
NOTE: Above numbers are our estimate based on AZN's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
AstraZeneca PLC (AZN) had its IPO on 1993-05-12, and is trader on NASDAQ stock exchange.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AZN website: https://www.astrazeneca.com
